Association between lithium treatment and vascular calcification in bipolar disorder: A retrospective cohort study
Journal of Affective Disorders · 2026
DOI: 10.1016/j.jad.2026.122416 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Affective Disorders, 2026. Verfasst von Jingya Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Joint Laboratory of Guangdong-Hong Kong-Macao Universities for Nutritional Metabolism and Precise Prevention and Control of…. Hauptthemen laut MEDLINE: Bipolar Disorder, Vascular Calcification, Coronary Artery Disease, Lithium Compounds. Die Arbeit nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shenzhen Science and Technology Innovation Program, National Science and Technology Major Project.
Abstract (Originalsprache)
BACKGROUND: Patients with bipolar disorder (BD) have an increased risk of cardiovascular disease, though the association between lithium treatment and vascular calcification remains unclear. This study aimed to investigate lithium therapy and vascular calcification and identify the clinical factors associated with aortic calcification (AC) and coronary artery calcification (CAC). METHODS: In this retrospective cohort study, 177 patients with BD who had available baseline and approximately 10-year follow-up chest radiographs were classified according to their lithium treatment status. AC and CAC were assessed using follow-up chest X-rays. Multivariable logistic regression analyses with least absolute shrinkage and selection operator (LASSO)-based variable selection were performed. Prediction models were developed and validated using a random split-sample approach. RESULTS: Lithium treatment was independently associated with lower odds of both AC (adjusted odds ratio [OR] = 0.11, 95% confidence interval [CI]: 0.03-0.32, P < 0.001) and CAC (adjusted OR = 0.19, 95% CI: 0.06-0.62, P = 0.006). Greater illness burden, reflected by higher mood episodes, was independently associated with AC. Traditional cardiovascular risk factors, including aging and diabetes, also contributed to vascular calcification. The LASSO-based prediction models showed acceptable exploratory performance in random split-sample validation. CONCLUSIONS: Lithium treatment was independently associated with lower odds of AC and CAC in patients with BD. The exploratory prediction models incorporating lithium exposure and other clinical factors may provide preliminary insights into vascular calcification assessment in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Joint Laboratory of Guangdong-Hong Kong-Macao Universities for Nutritional Metabolism and Precise Prevention and Control of Major Chronic Diseases, the Eighth Affiliated Hospital of Sun Yat-sen…
- Department of Psychiatry, Psychiatric Hospital of Guangzhou Civil Affairs Bureau, Guangzhou, 510030, China.
- Department of Cardiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.
Förderung
- National Natural Science Foundation of China
- Shenzhen Science and Technology Innovation Program
- National Science and Technology Major Project
Zitieren
APA
Jiang, J., Zheng, D., He, W., Liu, L., Huang, S., Chen, J., & Huang, H. (2026). Association between lithium treatment and vascular calcification in bipolar disorder: A retrospective cohort study. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2026.122416
Vancouver
Jiang J, Zheng D, He W, Liu L, Huang S, Chen J, et al. Association between lithium treatment and vascular calcification in bipolar disorder: A retrospective cohort study. Journal of Affective Disorders. 2026. doi:10.1016/j.jad.2026.122416
BibTeX
@article{Jiang2026,
author = {Jiang, Jingya and Zheng, Dongdong and He, Wanbing and Liu, Lianqi and Huang, Shuyan and Chen, Jie and Huang, Hui},
title = {Association between lithium treatment and vascular calcification in bipolar disorder: A retrospective cohort study},
journal = {Journal of Affective Disorders},
year = {2026},
doi = {10.1016/j.jad.2026.122416}
}
EUVIMED